Novel drug-loaded gelatin films and their sustained-release performance

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 90 B, Issue 2, 2009, Pages 939-944

  Lin, Mei ^a,b   Meng, Sheng ^a   Zhong, Wei ^a   Cai, Rui ^a   Du, Qiangguo ^a   Tomasik, Piotr ^c  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF AGRICULTURE IN KRAKOW   (Poland)

Author keywords

Diffusion; Gelatin; Microspheres; Poly caprolactone; Sustained release

Indexed keywords

DRUG DELIVERY; DRUG PRODUCTS; EMULSIFICATION; EMULSIONS; ENCAPSULATION; ORGANIC SOLVENTS;

CAPROLACTONE; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENCAPSULATION EFFICIENCY; GELATIN; GELATIN FILM; GELATIN MATRIX; MATRIX EROSION; MODEL DRUGS; OIL-IN-WATER EMULSIONS; PROLONGED RELEASE; SUSTAINED RELEASE; WATER UPTAKE;

MICROSPHERES;

GELATIN; IBUPROFEN; MICROSPHERE; POLYCAPROLACTONE;

ARTICLE; BIOFILM; CROSS LINKING; DRUG DELIVERY SYSTEM; EMULSION; ENCAPSULATION; PARTICLE SIZE; SURFACE PROPERTY; SUSTAINED DRUG RELEASE; WATER TRANSPORT;

EID: 67749149024     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31366     Document Type: Article

References (23)

1. Zhang YZ, Venugopal J, Huang ZM, Lim CT, Ramakrishna S. Cross-linking of the electrospun gelatine nanofibers. Polymer 2006;47:2911-2917.
2. Kuijpers AJ, Engbers GHM, Feijen J, De Smedt SC, Meyvis TKL, Demeester J, Krijgsveld J, Zaat SAJ, Dankert J. Characterization of the network structure of carbodiimide crosslinked gelatin gels. Macromolecules 1999;32:3325-3333.
3. Li JK, Wang N, Wu XS. Gelatin nanoencapsulation of protein/ peptide drugs using an emulsifier-free emulsion method. J Microencapsul 1998;15:163-172. (Pubitemid 28105132)
4. Cortesi R, Nastruzzi C, Davis SS. Sugar cross-linked gelatin for controlled release: Microspheres and disks. Biomaterials 1998;19:1641-1649. (Pubitemid 28512844)
5. Esposito E, Cortesi R, Nastruzzi C. Gelatin microspheres: Influence of preparation parameters and thermal treatment on chemico-physical and biopharmaceutical properties. Biomaterials 1996;17:2009-2020. (Pubitemid 26328942)
6. Choi YS, Hong SR, Lee YM, Song KW, Park MH, Nam YS. Study on gelatin-containing artificial skin. I. Preparation and characteristics of novel gelatin-alginate sponge. Biomaterials 1999;20:409-417.
7. Yakimets I, Wellner N, Smith AC, Wilson RH, Farhat I, Mitchel J. Mechanical properties with respect to water content of gelatin films in glassy state. Polymer 2005;46:12577-12585. (Pubitemid 41815302)
8. Tanaka T, Nagate T, Matsuda H. Acceleration of wound healing by gelatin film dressings with epidermal growth factor. J Vet Med Sci 2005;67:909-913. (Pubitemid 41436280)
9. Coardin T, Bah S, Livage J. Gelatin/silicate interactions: From nanoparticles to composite gels. Colloids Surf B Biointerfaces 2004;35:53-58. (Pubitemid 38553995)
10. Young S, Wong M, Tabata Y, Mikos AG. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J Control Release 2005;109:256-274. (Pubitemid 41737269)
11. Bajpai AK, Choubey J. Design of gelatin nanoparticles as swelling controlled delivery system for chloroquine phosphate. J Mater Sci Mater Med 2006;17:345-358.
12. Mi FL, Lin YM, Wu YB, Shyu SS, Tsai YH. Chitin/PLGA blend microspheres as a biodegradable drug-delivery system: Phase-separation, degradation and release behavior. Biomaterials 2002;23:3257-3267.
13. Siepmann J, Faisant N, Akiki J, Richard J, Benoit JP. Effect of the size of biodegradable microparticles drug release: Experiment and theory. J Control Release 2004;96:123-134. (Pubitemid 38438495)
14. Hitzman CJ, Elmquist WF, Wattenberg LW, Wiedmann TS. Development of a respirable, sustained release microcarrier for 5-fluorouracil. I. In vitro assessment of liposomes, microspheres, and lipid coated nanoparticles. J Pharm Sci 2006;95: 1114-1126.
15. Zhang Y, Zhu W, Wang BB, Yu L, Jing JD. Post fabrication encapsulation of model protein drugs in a negatively thermosensitive hydrogel. J Pharm Sci 2005;94:1676-1684. (Pubitemid 41360862)
16. Mu L, Feng SS. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin ETPGS. J Control Release 2003;86:33-48. (Pubitemid 35469120)
17. Dhanaraju MD, Gopinath D, Ahmed MR, Jayakumar R, Vamsadhara C. Characterization of polymeric poly(epsilon-caprolactone) injectable implant delivery system for the controlled delivery of contraceptive steroids. J Biomed Mater Res 2006; 76A:63-72. (Pubitemid 43075682)
18. Sinha R, Bansal K, Kaushik R, Kumria R, Trehan A. Poly-epsilon- caprolactone microspheres and nanospheres: An overview. Int J Pharm 2004;278:1-23. (Pubitemid 38670433)
19. Kim SY, Lee YM, Lee DJ, Kang JS. Toxic characteristics of methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) nanospheres: In vitro and in vivo studies in the normal mice. Biomaterials 2003;24:55-63.
20. O'Donnell PB, McGinity JW. Preparation of microspheres by the solvent evaporation technique. Adv Drug Deliv Rev 1997;28:25-42.
21. Frank A, Rath SK, Venkatraman SS. Controlled release from bioerodible polymers: Effect of drug type and polymer composition. J Control Release 2005;102:333-344. (Pubitemid 40093757)
22. Chavanpatil MD, Jain P, Chaudhari S, Shear R, Vavia PR. Novel sustained release, swellable and bioadhesive gastroretentive drug delivery system for ofloxacin. Int J Pharm 2006;316:86-92. (Pubitemid 43765689)
23. Gulsen D, Chauhan A. Effect of water content on transparency, swelling, lidocaine diffusion in p-HEMA gels. J Membr Sci 2006;269:35-48. (Pubitemid 41827984)